BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31306912)

  • 1. High-throughput screening of active compounds against human respiratory syncytial virus.
    Fu YH; Xu ZX; Jiang N; Zheng YP; Rameix-Welti MA; Jiao YY; Peng XL; Wang Y; Eleouet JF; Cen S; He JS
    Virology; 2019 Sep; 535():171-178. PubMed ID: 31306912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Characterization of a Recombinant Human Respiratory Syncytial Virus Encoding Enhanced Green Fluorescence Protein for Antiviral Drug Screening Assay.
    Xu M; Jiao YY; Fu YH; Jiang N; Zheng YB; Yan YF; Zhang M; Zheng YP; Zhu WY; Peng XL; He JS
    Biomed Res Int; 2018; 2018():8431243. PubMed ID: 29568767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay.
    Shambaugh C; Azshirvani S; Yu L; Pache J; Lambert SL; Zuo F; Esser MT
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice.
    Vasou A; Paulus C; Narloch J; Gage ZO; Rameix-Welti MA; Eléouët JF; Nevels M; Randall RE; Adamson CS
    Antiviral Res; 2018 Feb; 150():79-92. PubMed ID: 29037975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus.
    Cui R; Wang Y; Wang L; Li G; Lan K; Altmeyer R; Zou G
    Antiviral Res; 2016 Aug; 132():38-45. PubMed ID: 27210812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescence-based high-throughput antiviral compound screening assay against respiratory syncytial virus.
    Kwanten L; De Clerck B; Roymans D
    Methods Mol Biol; 2013; 1030():337-44. PubMed ID: 23821280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Hit Screening Cascade to Identify Respiratory Syncytial Virus (RSV) Inhibitors.
    Plant H; Stacey C; Tiong-Yip CL; Walsh J; Yu Q; Rich K
    J Biomol Screen; 2015 Jun; 20(5):597-605. PubMed ID: 25656237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
    Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phenotypic High-Throughput Screen with RSV-Infected Primary Human Small Airway Epithelial Cells (SAECs).
    Gobel J; Gartland M; Gurley SH; Kadwell S; Gillie D; Moore C; Goetz A
    J Biomol Screen; 2015 Jul; 20(6):729-38. PubMed ID: 25862685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen.
    Duvall JR; VerPlank L; Ludeke B; McLeod SM; Lee MD; Vishwanathan K; Mulrooney CA; Le Quement S; Yu Q; Palmer MA; Fleming P; Fearns R; Foley MA; Scherer CA
    Antiviral Res; 2016 Jul; 131():19-25. PubMed ID: 27059228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and validation of small interfering RNA on respiratory syncytial virus M2-2 gene: A potential approach in RNA interference on viral replication.
    Chin VK; Atika Aziz NA; Hudu SA; Harmal NS; Syahrilnizam A; Jalilian FA; Zamberi S
    J Virol Methods; 2016 Oct; 236():117-125. PubMed ID: 27432115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen.
    Laganas VA; Dunn EF; McLaughlin RE; Tiong-Yip CL; Yuzhakov O; Isabella VM; Hill P; Yu Q
    Antiviral Res; 2015 Mar; 115():71-4. PubMed ID: 25542974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and evaluation of anti-respiratory syncytial virus compounds in cultured cells.
    Lundin A; Bergström T; Trybala E
    Methods Mol Biol; 2013; 1030():345-63. PubMed ID: 23821281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a high-throughput replicon assay for the identification of respiratory syncytial virus inhibitors.
    Tiong-Yip CL; Plant H; Sharpe P; Fan J; Rich K; Gorseth E; Yu Q
    Antiviral Res; 2014 Jan; 101():75-81. PubMed ID: 24246168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
    Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
    Yan D; Weisshaar M; Lamb K; Chung HK; Lin MZ; Plemper RK
    Biochemistry; 2015 Sep; 54(36):5589-604. PubMed ID: 26307636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Intracellular Ion Homeostasis for the Control of Respiratory Syncytial Virus.
    Norris MJ; Malhi M; Duan W; Ouyang H; Granados A; Cen Y; Tseng YC; Gubbay J; Maynes J; Moraes TJ
    Am J Respir Cell Mol Biol; 2018 Dec; 59(6):733-744. PubMed ID: 30095982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput screening strategy to overcome virus instability.
    Rasmussen L; Maddox C; Moore BP; Severson W; White EL
    Assay Drug Dev Technol; 2011 Apr; 9(2):184-90. PubMed ID: 21050067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.